Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Tassin

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
British Journal of Pharmacology|March 1, 1975
Loss of noradrenergic and dopaminergic terminals in the chronically isolated cerebral cortex of the catJ C Hirsch, J P Tassin, A M Thierry
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 1998
Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamineL Darracq, G Blanc, J Glowinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injectionsP Vezina, G Blanc, J Glowinski, et al.
Brain Research|January 23, 1999
Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptorsF Trovero, D Brochet, J P Tassin, et al.
Neuroscience Letters|February 28, 1994
Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the ratP Vezina, D Hervé, J Glowinski, et al.
Brain Research|April 15, 1982
Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the ratD Herve, G Blanc, J Glowinski, et al.
The European Journal of Neuroscience|January 1, 1991
Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine ReceptorP. Vezina, G. Blanc, J. Glowinski, et al.
Journal of Clinical Pharmacy and Therapeutics|December 21, 2000
Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depressionP Boyer, J P Tassin, B Falissart, et al.
Synapse (New York, N.Y.)|February 1, 1994
Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbensP Vezina, G Blanc, J Glowinski, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 11, 1997
Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detectionJ P Tassin, J Dubois, G Atassi, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|March 1, 1975
Loss of noradrenergic and dopaminergic terminals in the chronically isolated cerebral cortex of the catJ C Hirsch, J P Tassin, A M Thierry
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 1998
Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamineL Darracq, G Blanc, J Glowinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injectionsP Vezina, G Blanc, J Glowinski, et al.
Brain Research|January 23, 1999
Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptorsF Trovero, D Brochet, J P Tassin, et al.
Neuroscience Letters|February 28, 1994
Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the ratP Vezina, D Hervé, J Glowinski, et al.
Brain Research|April 15, 1982
Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the ratD Herve, G Blanc, J Glowinski, et al.
The European Journal of Neuroscience|January 1, 1991
Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine ReceptorP. Vezina, G. Blanc, J. Glowinski, et al.
Journal of Clinical Pharmacy and Therapeutics|December 21, 2000
Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depressionP Boyer, J P Tassin, B Falissart, et al.
Synapse (New York, N.Y.)|February 1, 1994
Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbensP Vezina, G Blanc, J Glowinski, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 11, 1997
Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detectionJ P Tassin, J Dubois, G Atassi, et al.
Pageof 11